The Weight Loss Market Can Surge to $400B by 2032 - These Stocks Will Rule It

  • 📰 Investingcom
  • ⏱ Reading Time:
  • 54 sec. here
  • 4 min. at publisher
  • 📊 Quality Score:
  • News: 32%
  • Publisher: 53%

Eli Lilly And Company News

Pfizer Inc,Novo Nordisk A/S

Stocks Analysis by The Tokenist (Timothy Fries) covering: Eli Lilly and Company, Pfizer Inc, Novo Nordisk A/S. Read The Tokenist (Timothy Fries)'s latest article on Investing.com

Building on the Industrial Revolution, the modern sedentary age coupled with abundant cheap food has greatly exacerbated the obesity problem. According to CDC data, 1 in 5 adults in the US and territories could be classified as obese. Even worse, 22 states had obesity rates above 35% in 2022.

For shareholders, this looming narrative had a suppressive effect on PFE stock as the vaccine demand died out. From the all-time high of $55 in December 2021, PFE shares have had a 52-week average of $29.96, aligning with the present price of $28.66 per share. Danuglipron belongs to the family of GLP-1 agonists, which are now prevalent in the treatment of obesity-related issues, of which diabetes is the main driver. Optimization studies will take place in the second half of 2024 to determine dosing.

Improving on obesity and diabetes treatments, the company now counts on Mounjaro, Zepbound and Jardiance for revenue growth. In Q1 earnings, these drugs were mainly responsible for the quarter’s 26% sales boost of $8.76 billion, delivering a $2.2 billion net income. Although China also approved Novo Nordisk’s Ozempic in 2021 and Wegovy in late June, Novo Nordisk is likely to face a wind down as the patent on semaglutide expires in 2026. At that point, we are likely to see a flood of Chinese generic obesity drugs, a similar pattern that happened with the

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 450. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

These 3 Clinical-Stage Biotech Stocks Can Offer Exponential GainsStocks Analysis by The Tokenist (Timothy Fries) covering: Pfizer Inc, Ocuphire Pharma Inc, Rocket Pharmaceuticals Inc, Arvinas Inc. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »

3 Bitcoin Mining Stocks to Hold as BTC Becomes More MainstreamStocks Analysis by The Tokenist (Timothy Fries) covering: NVIDIA Corporation, Terawulf Inc, Bitcoin, Iris Energy Ltd. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »

Stocks to Watch Today: Boeing, Occidental Petroleum, NextEra EnergyStocks Analysis by The Tokenist (Timothy Fries) covering: Boeing Co, Occidental Petroleum Corporation, Nextera Energy Inc, Berkshire Hathaway Inc Class A. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »

Why Meta Is a Dark Horse in the Current AI Market CycleStocks Analysis by The Tokenist (Timothy Fries) covering: Meta Platforms Inc. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »

These 3 Stocks Are Cathie Wood’s Largest BetsStocks Analysis by The Tokenist (Timothy Fries) covering: S&P 500, Alphabet Inc Class A, Apple Inc, Amazon.com Inc. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »